TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
EBOS Group Limited ( (AU:EBO) ) just unveiled an update.
EBOS Group Limited announced the cessation of 2,192 performance rights due to unmet conditions, as detailed in their recent notification. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational adjustments and strategic focus.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and pharmaceutical industry, providing a range of products and services including medical supplies, pharmaceuticals, and related healthcare solutions. The company focuses on serving markets in Australia and New Zealand, positioning itself as a key player in the distribution and logistics of healthcare products.
Average Trading Volume: 138,807
Technical Sentiment Signal: Sell
Current Market Cap: A$5.03B
Learn more about EBO stock on TipRanks’ Stock Analysis page.